Portfolio Holdings Detail for ISIN IE00BDZVHG35
| Stock Name / Fund | iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) |
| Issuer | Blackrock |
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 67
| ETF Ticker | BTEE(USD) LSE |
| ETF Ticker | BTEE.L(GBP) LSE |
Holdings detail for ARCT
| Stock Name | Arcturus Therapeutics Holdings Inc |
| Ticker | ARCT(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US03969T1097 |
Show aggregate ARCT holdings
News associated with ARCT
- Arcturus Therapeutics (NASDAQ:ARCT) Given New $54.00 Price Target at Leerink Partners
- Arcturus Therapeutics (NASDAQ:ARCT – Free Report) had its price target cut by Leerink Partners from $63.00 to $54.00 in a report released on Friday,Benzinga reports. They currently have an outperform rating on the biotechnology company’s stock. ARCT has been the subject of a number of other reports. Canaccord Genuity Group decreased their target price on […] - 2025-08-25 02:12:53
- Mitsubishi UFJ Asset Management Co. Ltd. Grows Position in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)
- Mitsubishi UFJ Asset Management Co. Ltd. increased its position in shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Free Report) by 9.2% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 14,693 shares of the biotechnology company’s stock after buying an additional 1,232 shares during […] - 2025-08-15 04:46:53
- Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Receives Average Rating of “Buy” from Brokerages
- Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report) have received an average rating of “Buy” from the seven analysts that are currently covering the firm, MarketBeat.com reports. Seven analysts have rated the stock with a buy recommendation. The average 1 year target price among analysts that have issued ratings on the stock […] - 2025-08-12 04:42:57
- Empire Life Investments Inc. Sells 14,554 Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)
- Empire Life Investments Inc. trimmed its position in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Free Report) by 5.2% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 264,909 shares of the biotechnology company’s stock after selling 14,554 shares during the period. […] - 2025-08-04 04:44:57
- Alps Advisors Inc. Trims Stock Holdings in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)
- Alps Advisors Inc. reduced its holdings in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Free Report) by 8.9% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 19,949 shares of the biotechnology company’s stock after selling 1,952 shares during the quarter. Alps Advisors Inc. owned approximately […] - 2025-07-18 04:49:09
- Sumitomo Mitsui Trust Group Inc. Reduces Stock Position in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)
- Sumitomo Mitsui Trust Group Inc. reduced its position in shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Free Report) by 6.7% in the first quarter, HoldingsChannel.com reports. The firm owned 1,926,084 shares of the biotechnology company’s stock after selling 138,966 shares during the period. Sumitomo Mitsui Trust Group Inc. owned about 0.07% of Arcturus Therapeutics […] - 2025-07-04 05:12:59
- Arcturus Therapeutics (NASDAQ:ARCT) Stock Crosses Below 200 Day Moving Average – Time to Sell?
- Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report)’s share price crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $14.13 and traded as low as $13.74. Arcturus Therapeutics shares last traded at $14.41, with a volume of 517,333 shares changing hands. Wall Street Analyst […] - 2025-06-27 05:22:55
- Arcturus Therapeutics (NASDAQ:ARCT) Now Covered by Scotiabank
- Scotiabank began coverage on shares of Arcturus Therapeutics (NASDAQ:ARCT – Get Free Report) in a report released on Wednesday, Marketbeat Ratings reports. The brokerage set a “sector outperform” rating and a $32.00 price target on the biotechnology company’s stock. Scotiabank’s price objective would suggest a potential upside of 151.37% from the company’s previous close. A […] - 2025-05-30 02:38:46
- Cresset Asset Management LLC Sells 2,198 Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)
- Cresset Asset Management LLC decreased its position in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Free Report) by 16.0% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 11,511 shares of the biotechnology company’s stock after selling 2,198 shares during the period. Cresset Asset Management LLC’s holdings in […] - 2025-05-19 05:02:55
- Arcturus Therapeutics (NASDAQ:ARCT) Given New $66.00 Price Target at Canaccord Genuity Group
- Arcturus Therapeutics (NASDAQ:ARCT – Free Report) had its target price reduced by Canaccord Genuity Group from $68.00 to $66.00 in a research note issued to investors on Tuesday morning,Benzinga reports. They currently have a buy rating on the biotechnology company’s stock. ARCT has been the topic of a number of other research reports. HC Wainwright […] - 2025-05-14 04:58:54
- Hsbc Holdings PLC Increases Stake in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)
- Hsbc Holdings PLC grew its position in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Free Report) by 11.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 25,368 shares of the biotechnology company’s stock after acquiring an additional 2,673 shares during the […] - 2025-05-08 06:07:00
- Barclays PLC Lowers Position in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)
- Barclays PLC trimmed its position in shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Free Report) by 10.9% in the 4th quarter, Holdings Channel.com reports. The firm owned 60,082 shares of the biotechnology company’s stock after selling 7,333 shares during the period. Barclays PLC’s holdings in Arcturus Therapeutics were worth $1,020,000 as of its most […] - 2025-05-06 04:38:59
- Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Stock Holdings Lessened by Franklin Resources Inc.
- Franklin Resources Inc. lessened its holdings in shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Free Report) by 3.1% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 100,677 shares of the biotechnology company’s stock after selling 3,259 shares during the period. […] - 2025-04-15 05:32:54
- Mitsubishi UFJ Asset Management Co. Ltd. Purchases 4,647 Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)
- Mitsubishi UFJ Asset Management Co. Ltd. lifted its position in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Free Report) by 52.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,461 shares of the biotechnology company’s stock after acquiring an additional 4,647 […] - 2025-04-04 05:12:56
- AlphaQuest LLC Sells 12,668 Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)
- AlphaQuest LLC cut its stake in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Free Report) by 63.9% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,142 shares of the biotechnology company’s stock after selling 12,668 shares during the period. AlphaQuest LLC’s holdings in […] - 2025-03-19 06:06:45
- Arcturus Therapeutics (NASDAQ:ARCT) Given New $68.00 Price Target at Canaccord Genuity Group
- Arcturus Therapeutics (NASDAQ:ARCT – Get Free Report) had its price objective reduced by stock analysts at Canaccord Genuity Group from $74.00 to $68.00 in a research report issued on Monday,Benzinga reports. The firm presently has a “buy” rating on the biotechnology company’s stock. Canaccord Genuity Group’s price objective would indicate a potential upside of 414.76% […] - 2025-03-12 04:08:56
- Arcturus Therapeutics (NASDAQ:ARCT) Share Price Passes Below 200-Day Moving Average – Here’s Why
- Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report) passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $18.81 and traded as low as $16.51. Arcturus Therapeutics shares last traded at $16.69, with a volume of 364,852 shares. Wall Street Analysts Forecast Growth Several research […] - 2025-02-25 06:50:59
- Spire Wealth Management Increases Stock Holdings in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)
- Spire Wealth Management increased its holdings in shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Free Report) by 393.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 13,478 shares of the biotechnology company’s stock after buying an additional 10,746 shares during the […] - 2025-02-07 07:05:06
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) ARCT holdings
| Date | Number of ARCT Shares Held | Base Market Value of ARCT Shares | Local Market Value of ARCT Shares | Change in ARCT Shares Held | Change in ARCT Base Value | Current Price per ARCT Share Held | Previous Price per ARCT Share Held |
|---|
| 2026-02-09 (Monday) | 21,248 | USD 159,997 | USD 159,997 | | | | |
| 2026-02-06 (Friday) | 21,202 | USD 160,499 | USD 160,499 | 47 | USD 4,587 | USD 7.56999 | USD 7.36998 |
| 2026-02-02 (Monday) | 21,155 | USD 155,912 | USD 155,912 | 0 | USD -2,116 | USD 7.36998 | USD 7.47001 |
| 2026-01-30 (Friday) | 21,155 | USD 158,028 | USD 158,028 | 94 | USD -1,404 | USD 7.47001 | USD 7.57001 |
| 2026-01-29 (Thursday) | 21,061 | USD 159,432 | USD 159,432 | 47 | USD 2,668 | USD 7.57001 | USD 7.45998 |
| 2026-01-27 (Tuesday) | 21,014 | USD 156,764 | USD 156,764 | 47 | USD 2,447 | USD 7.45998 | USD 7.35999 |
| 2026-01-26 (Monday) | 20,967 | USD 154,317 | USD 154,317 | 0 | USD -3,565 | USD 7.35999 | USD 7.53002 |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of ARCT by Blackrock for IE00BDZVHG35
Show aggregate share trades of ARCT| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2026-02-06 | BUY | 47 | | | 7.570* | | - |
| 2026-01-30 | BUY | 94 | 7.600 | 7.180 | 7.222 | USD 679 | - |
| 2026-01-29 | BUY | 47 | 7.690 | 7.240 | 7.285 | USD 342 | - |
| 2026-01-27 | BUY | 47 | 7.590 | 7.330 | 7.356 | USD 346 | - |
| 2026-01-23 | BUY | 94 | 7.760 | 7.410 | 7.445 | USD 700 | - |
| 2026-01-22 | BUY | 47 | 7.890 | 7.320 | 7.377 | USD 347 | - |
| 2026-01-15 | BUY | 98 | 7.820 | 7.450 | 7.487 | USD 734 | - |
| 2026-01-14 | BUY | 98 | 7.790 | 7.420 | 7.457 | USD 731 | - |
| 2026-01-12 | BUY | 98 | 7.570 | 6.914 | 6.980 | USD 684 | - |
| 2026-01-09 | BUY | 147 | 6.970 | 6.700 | 6.727 | USD 989 | - |
| 2026-01-07 | BUY | 98 | 6.990 | 6.650 | 6.684 | USD 655 | - |
| 2026-01-02 | BUY | 49 | 6.310 | 6.110 | 6.130 | USD 300 | - |
| 2025-12-30 | BUY | 49 | 6.280 | 6.090 | 6.109 | USD 299 | - |
| 2025-12-23 | SELL | -588 | 6.610 | 6.340 | 6.367 | USD -3,744 | - |
| 2025-12-17 | SELL | -245 | 7.210 | 6.490 | 6.562 | USD -1,608 | - |
| 2025-12-16 | SELL | -49 | 7.360 | 6.920 | 6.964 | USD -341 | - |
| 2025-12-15 | BUY | 98 | 7.528 | 7.115 | 7.156 | USD 701 | - |
| 2025-12-11 | BUY | 98 | 7.759 | 7.465 | 7.494 | USD 734 | - |
| 2025-12-04 | BUY | 980 | 6.846 | 6.470 | 6.508 | USD 6,377 | - |
| 2025-12-02 | BUY | 735 | 6.500 | 6.070 | 6.113 | USD 4,493 | - |
| 2025-11-28 | BUY | 49 | 6.895 | 6.745 | 6.760 | USD 331 | - |
| 2025-11-26 | BUY | 147 | 6.895 | 6.600 | 6.629 | USD 975 | - |
| 2025-11-26 | BUY | 147 | 6.895 | 6.600 | 6.629 | USD 975 | - |
| 2025-11-25 | BUY | 245 | 6.840 | 6.320 | 6.372 | USD 1,561 | - |
| 2025-11-24 | BUY | 49 | 6.380 | 6.070 | 6.101 | USD 299 | - |
| 2025-11-20 | SELL | -196 | 6.380 | 5.855 | 5.908 | USD -1,158 | - |
| 2025-11-19 | BUY | 49 | 6.690 | 6.020 | 6.087 | USD 298 | - |
| 2025-11-18 | BUY | 294 | 6.820 | 6.570 | 6.595 | USD 1,939 | - |
| 2025-11-17 | BUY | 98 | 7.320 | 6.720 | 6.780 | USD 664 | - |
| 2025-11-14 | BUY | 49 | 7.650 | 7.260 | 7.299 | USD 358 | - |
| 2025-11-12 | BUY | 49 | 8.649 | 8.090 | 8.146 | USD 399 | - |
| 2025-11-10 | BUY | 48 | 9.020 | 8.550 | 8.597 | USD 413 | - |
| 2025-11-06 | BUY | 48 | 8.620 | 8.237 | 8.275 | USD 397 | - |
| 2025-11-04 | BUY | 49 | 9.400 | 8.840 | 8.896 | USD 436 | - |
| 2025-10-30 | BUY | 245 | 9.980 | 9.410 | 9.467 | USD 2,319 | - |
| 2025-10-29 | BUY | 98 | 9.440 | 9.944 | 9.893 | USD 970 | - |
| 2025-10-23 | SELL | -188 | 12.000 | 12.100 | 12.090 | USD -2,273 | - |
| 2025-10-20 | BUY | 94 | 21.510 | 22.600 | 22.491 | USD 2,114 | - |
| 2025-10-17 | BUY | 235 | 20.660 | 22.130 | 21.983 | USD 5,166 | - |
| 2025-10-15 | BUY | 376 | 21.570 | 22.220 | 22.155 | USD 8,330 | - |
| 2025-10-03 | BUY | 336 | 22.560 | 23.600 | 23.496 | USD 7,895 | - |
| 2025-10-02 | BUY | 48 | 21.880 | 21.940 | 21.934 | USD 1,053 | - |
| 2025-09-30 | BUY | 96 | 18.430 | 19.050 | 18.988 | USD 1,823 | - |
| 2025-09-26 | BUY | 96 | 22.170 | 22.400 | 22.377 | USD 2,148 | - |
| 2025-09-25 | BUY | 96 | 20.310 | 20.500 | 20.481 | USD 1,966 | - |
| 2025-09-18 | BUY | 48 | 19.620 | 19.690 | 19.683 | USD 945 | - |
| 2025-09-17 | BUY | 144 | 18.050 | 18.590 | 18.536 | USD 2,669 | - |
| 2025-09-11 | SELL | -48 | 18.040 | 18.690 | 18.625 | USD -894 | - |
| 2025-09-10 | BUY | 96 | 17.990 | 18.050 | 18.044 | USD 1,732 | - |
| 2025-07-17 | SELL | -94 | 13.540 | 13.850 | 13.819 | USD -1,299 | - |
| 2025-07-11 | SELL | -384 | 13.780 | 14.440 | 14.374 | USD -5,520 | - |
| 2025-07-02 | BUY | 2,640 | 13.620 | 14.090 | 14.043 | USD 37,074 | - |
| 2025-06-25 | BUY | 96 | 13.950 | 14.010 | 14.004 | USD 1,344 | - |
| 2025-06-11 | BUY | 98 | 12.440 | 13.320 | 13.232 | USD 1,297 | - |
| 2025-06-10 | BUY | 98 | 12.900 | 13.620 | 13.548 | USD 1,328 | - |
| 2025-06-04 | SELL | -49 | 12.260 | 13.270 | 13.169 | USD -645 | - |
| 2025-04-23 | BUY | 48 | 12.650 | 13.660 | 13.559 | USD 651 | - |
| 2025-04-10 | SELL | -384 | 9.350 | 9.530 | 9.512 | USD -3,653 | - |
| 2025-04-08 | SELL | -49 | 8.910 | 9.460 | 9.405 | USD -461 | - |
| 2025-04-07 | SELL | -49 | 9.090 | 9.130 | 9.126 | USD -447 | - |
| 2025-04-04 | SELL | -245 | 9.110 | 9.350 | 9.326 | USD -2,285 | - |
| 2025-04-01 | BUY | 196 | 9.430 | 10.490 | 10.384 | USD 2,035 | - |
| 2025-03-31 | SELL | -147 | 10.590 | 11.240 | 11.175 | USD -1,643 | - |
| 2025-03-21 | BUY | 1,714 | 12.880 | 12.930 | 12.925 | USD 22,153 | - |
| 2025-03-14 | SELL | -688 | 14.080 | 14.290 | 14.269 | USD -9,817 | - |
| 2025-03-07 | SELL | -86 | 14.550 | 15.400 | 15.315 | USD -1,317 | - |
| 2025-03-04 | SELL | -43 | 15.490 | 15.950 | 15.904 | USD -684 | - |
| 2025-02-25 | BUY | 86 | 16.060 | 16.940 | 16.852 | USD 1,449 | - |
| 2025-02-19 | SELL | -43 | 17.320 | 17.610 | 17.581 | USD -756 | - |
| 2025-02-13 | BUY | 126 | 16.410 | 16.460 | 16.455 | USD 2,073 | - |
| 2025-02-12 | BUY | 42 | 15.860 | 16.400 | 16.346 | USD 687 | - |
| 2025-02-11 | BUY | 168 | 16.070 | 16.250 | 16.232 | USD 2,727 | - |
| 2024-12-30 | SELL | -1,863 | 16.580 | 16.910 | 16.877 | USD -31,442 | - |
| 2024-11-18 | SELL | -705 | 16.270 | 17.370 | 17.260 | USD -12,168 | - |
| 2024-11-08 | SELL | -47 | 19.630 | 19.930 | 19.900 | USD -935 | - |
| 2024-10-21 | SELL | -48 | 20.880 | 21.200 | 21.168 | USD -1,016 | - |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of ARCT
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-09-19 | 263,050 | 654 | 445,276 | 59.1% |
| 2025-09-18 | 243,055 | 128 | 528,086 | 46.0% |
| 2025-09-17 | 153,506 | 0 | 239,673 | 64.0% |
| 2025-09-16 | 168,941 | 250 | 384,536 | 43.9% |
| 2025-09-15 | 81,742 | 0 | 158,515 | 51.6% |
| 2025-09-12 | 147,710 | 0 | 262,855 | 56.2% |
| 2025-09-11 | 99,586 | 3,939 | 173,748 | 57.3% |
| 2025-09-10 | 82,216 | 10 | 142,607 | 57.7% |
| 2025-09-09 | 96,679 | 11 | 151,444 | 63.8% |
| 2025-09-08 | 83,377 | 25 | 159,527 | 52.3% |
| 2025-09-05 | 87,759 | 1 | 183,086 | 47.9% |
| 2025-09-04 | 84,271 | 91 | 145,296 | 58.0% |
| 2025-09-03 | 72,068 | 1 | 141,174 | 51.0% |
| 2025-09-02 | 39,080 | 0 | 82,147 | 47.6% |
| 2025-08-29 | 80,961 | 257 | 179,959 | 45.0% |
| 2025-08-28 | 88,089 | 98 | 225,068 | 39.1% |
| 2025-08-27 | 38,893 | 0 | 86,060 | 45.2% |
| 2025-08-26 | 28,812 | 20 | 94,454 | 30.5% |
| 2025-08-25 | 48,836 | 1,396 | 130,338 | 37.5% |
| 2025-08-22 | 63,146 | 22 | 161,240 | 39.2% |
| 2025-08-21 | 71,233 | 1,783 | 200,636 | 35.5% |
| 2025-08-20 | 88,968 | 1 | 205,868 | 43.2% |
| 2025-08-19 | 124,219 | 1,874 | 282,776 | 43.9% |
| 2025-08-18 | 349,598 | 677 | 543,676 | 64.3% |
| 2025-08-15 | 182,967 | 6 | 365,205 | 50.1% |
| 2025-08-14 | 296,713 | 19,441 | 723,755 | 41.0% |
| 2025-08-13 | 320,831 | 2,493 | 788,749 | 40.7% |
| 2025-08-12 | 344,702 | 2,010 | 749,296 | 46.0% |
| 2025-08-11 | 147,071 | 0 | 479,081 | 30.7% |
| 2025-08-08 | 88,438 | 0 | 154,473 | 57.3% |
| 2025-08-07 | 67,886 | 30 | 120,286 | 56.4% |
| 2025-08-06 | 89,157 | 30 | 150,307 | 59.3% |
| 2025-08-05 | 65,364 | 40 | 123,323 | 53.0% |
| 2025-08-04 | 54,407 | 0 | 108,262 | 50.3% |
| 2025-08-01 | 79,124 | 113 | 125,159 | 63.2% |
| 2025-07-31 | 74,466 | 225 | 148,216 | 50.2% |
| 2025-07-30 | 75,710 | 19,477 | 219,171 | 34.5% |
| 2025-07-29 | 201,694 | 2,041 | 281,192 | 71.7% |
| 2025-07-28 | 42,509 | 176 | 109,533 | 38.8% |
| 2025-07-25 | 111,404 | 1,103 | 158,920 | 70.1% |
| 2025-07-24 | 34,551 | 514 | 93,849 | 36.8% |
| 2025-07-23 | 85,654 | 2,416 | 153,963 | 55.6% |
| 2025-07-22 | 44,806 | 0 | 104,405 | 42.9% |
| 2025-07-21 | 46,543 | 0 | 95,176 | 48.9% |
| 2025-07-18 | 43,139 | 102 | 84,128 | 51.3% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Note: All information is provided as is without warranty and should be used for indicative purposes only.
You should independently check data before making any investment decision.
This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.
Copyright Market Footprint Ltd. Privacy Policy